| Realtime | Geld | Brief | Zeit |
|---|---|---|---|
| 6,950 | 7,150 | 18:28 |
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| 07:06 | SMAIO Announces a €3.6 Million Capital Increase to Support Its Long-Term Growth Momentum | 219 | Business Wire | Capital increase totaling €3.6 million gross through the issuance of shares with stock warrants (ABSAs) at a price of €7 per share
4 warrants will entitle the holder to subscribe for one... ► Artikel lesen | |
| 20.01. | SMAIO Reports 2025 Sales of €9.2m, Representing an Increase of +67% | 284 | Business Wire | U.S. sales rose by +138% to €7m, and by +160% to $7.9m (excluding currency effects).
Strong growth across North American centers that were already active in 2024 (+130%). 11 new... ► Artikel lesen | |
| 08.01. | SMAIO: 2026 Financial Calendar | 355 | Business Wire | Regulatory News:
SMAIO (Software, Machines and Adaptive Implants in Orthopaedics Euronext Growth Paris, ISIN: FR0014005I80 Ticker: ALSMA), a French-American player specialized in complex spine... ► Artikel lesen | |
| 06.01. | SMAIO Obtains €2.0m in Non-Dilutive Financing | 362 | Business Wire | €1.0m in the form of a 0% interest loan co-financed by the European Union, the Auvergne-Rhône-Alpes Region and Bpifrance, with a repayment deferral period of two and a half years €1.0m... ► Artikel lesen | |
| S.M.A.I.O SA Aktie jetzt für 0€ handeln | |||||
| 19.12.25 | SMAIO Successfully Continues Its Think Tanks Focused on Promoting Its Innovative Solutions in the United States | 469 | Business Wire | New attendance record at the New York session, bringing together nearly 60 experts from the spine sector, including over 40 surgeons
Regulatory News:
SMAIO (Software, Machines and Adaptative... ► Artikel lesen | |
| 24.11.25 | SMAIO appoints Matthieu Ville as chief commercial officer | 8 | Investing.com | ||
| 24.11.25 | SMAIO Appoints Matthieu Ville as Chief Commercial Officer to Accelerate Commercialization and Strengthen Its Leadership in Spinal Realignment | 280 | Business Wire | Matthieu Ville brings over 15 years of experience in medical marketing in the United States.
Regulatory News:
SMAIO (Software, Machines and Adaptative Implants in Orthopaedics- Euronext Growth... ► Artikel lesen | |
| 03.11.25 | DALLAS - Dr. Tenner Guillaume joins SMAIO's US scientific advisory board | 4 | Investing.com | ||
| 03.11.25 | SMAIO Adds a New High-Profile Member to Its Scientific Advisory Board in the United States | 251 | Business Wire | Appointment of Dr. Tenner Guillaume, Orthopaedic spine surgeon who specializes in spinal deformity at Gillette Children's Hospital (St. Paul, Minnesota). SMAIO's US scientific advisory board... ► Artikel lesen | |
| 22.10.25 | SMAIO Signs a New Distribution Agreement for Its Open Platform KEOPS-4ME With Orthofix in the U.S. | 460 | Business Wire | Orthofix is a global medical technology company focused on healing musculoskeletal pathologies The distribution arrangement is part of SMAIO's collaborative strategy aimed at deploying... ► Artikel lesen | |
| 17.10.25 | SMAIO H1 Sales Increase | 1 | RTTNews | ||
| 14.10.25 | SMAIO Announces Strong First-Half 2025 Results and Robust Growth in Business Activity in the Third Quarter of 2025 | 291 | Business Wire |
Strong sales growth in H1 2025: +126% to €5.0 million
Increase in gross margin in H1 2025 to 85% vs. 64% in H1 2024
Significant improvement in EBITDA (+96%) reaching break-even (vs.... ► Artikel lesen | |
| 24.09.25 | SMAIO Signs the First Major Distribution Agreement for Its Open Platform KEOPS-4ME with Highridge Medical in the U.S. | 377 | Business Wire | Highridge Medical is one of the world's largest privately held spine companies The partnership represents a key milestone in further expanding SMAIO's business activity in the U.S. and driving... ► Artikel lesen | |
| 16.07.25 | SMAIO Announces Significant Sales Increase in H1 2025 | 376 | Business Wire | Sales H1 2025: +126% to €5 million Acceleration of business activity in the United States (+360% to €3.8 million):
H1 2025 sales1 higher than full-year 2024 sales
More than... ► Artikel lesen | |
| 12.05.25 | SMAIO Announces the Finalization of a €2.5 Million Fund-Raising, Consisting of a €1.5 Million Capital Increase and a €1 Million Convertible Bond Issue | 433 | Business Wire | The transaction was fully subscribed by NextStage AM, in accordance with the terms previously communicated
Regulatory News:
This press release may not be published, distributed or disseminated... ► Artikel lesen | |
| 15.04.25 | SMAIO Announces a €2.5 Million Fund-Raising, Consisting of a €1.5 Million Capital Increase and a €1 Million Convertible Bond Issue | 610 | Business Wire | Regulatory News:
This press release may not be published, distributed or disseminated, directly or indirectly, in the United States of America or Canada, Australia, Japan or South Africa.
SMAIO... ► Artikel lesen | |
| 15.04.25 | SMAIO Announces Consolidated Results for 2024 and Record Sales Performance in Q1 2025 | 595 | Business Wire | Sharp increase in sales, up +114%1 to €5.5 million in 2024 and +140% to €2.5 million in Q1 2025
Improvement in the margin rate on implant sales to 79% in 2024, vs. 71% at the end of 2023... ► Artikel lesen |
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| FRESENIUS | 46,730 | +0,71 % | JEFFERIES stuft Fresenius SE auf 'Buy' | NEW YORK (dpa-AFX Analyser) - Das Analysehaus Jefferies hat das Kursziel für Fresenius von 55 auf 57 Euro angehoben und die Einstufung auf "Buy" belassen. Analyst James Vane-Tempest hob am Sonntag im... ► Artikel lesen | |
| SIEMENS HEALTHINEERS | 40,410 | -0,22 % | Siemens Healthineers: Stabilität als strategischer Vorteil | ||
| FRESENIUS MEDICAL CARE | 39,480 | -0,55 % | BARCLAYS stuft FMC FRESENIUS MEDICAL CARE AG auf 'Equal Weight' | LONDON (dpa-AFX Analyser) - Die britische Investmentbank Barclays hat das Kursziel für FMC von 47,50 auf 46,50 Euro gesenkt und die Einstufung auf "Equal Weight" belassen. Das Wachstum der Behandlungszahlen... ► Artikel lesen | |
| GERRESHEIMER | 18,990 | +4,80 % | Kursexplosion und Kursalarm! Gerresheimer, Nordex und KI-Profiteuer American Atomics! | Kursexplosion bei Nordex. Nach starken Quartalszahlen schießt die Aktie an einem Tag um rund 17 % nach oben. Das Unternehmen schwimmt auf einer Erfolgswelle und der Auftragsbestand deutet darauf hin... ► Artikel lesen | |
| CARL ZEISS MEDITEC | 25,040 | -1,34 % | INDEX-MONITOR: Lufthansa verpasst Dax-Rückkehr - Nur Wechsel in MDax und SDax | ZUG (dpa-AFX) - Die Aktien von Lufthansa haben die Rückkehr in den deutschen Leitindex Dax verpasst. Wie der zur Deutschen Börse gehörende Index-Anbieter Stoxx am späten Mittwochabend mitteilte, bleibt... ► Artikel lesen | |
| OTTOBOCK | 57,60 | +0,70 % | Ottobock greift nach der "Gedanken-Hand": 5 Mio. US-Dollar in Neuro-Implantate - nächster Gamechanger in der Prothetik? | Ottobock setzt beim nächsten Innovationssprung in der Prothetik auf eine klare Botschaft: Kapital plus Kontrolle. Im Rahmen einer Series-A-Finanzierung investiert der Human-Bionics-Marktführer 5 Mio.... ► Artikel lesen | |
| UNITEDHEALTH | 246,30 | -0,98 % | UnitedHealth-Aktie: Schockmeldung - droht der komplette Absturz? | ||
| DRAEGERWERK | 87,60 | -0,23 % | Draegerwerk AG & Co. KGaA: Zollentlastung bereits eingepreist, Aufwärtspotenzial wird kleiner, Kursziel erhöht; auf HALTEN gestuft. | Die Zollerlassungen in den USA bieten einen inkrementellen Unterstützungseffekt für die Draegerwerk, jedoch wird der Nutzen voraussichtlich schrittweise erfolgen. Während bestimmte Zölle aufgehoben... ► Artikel lesen | |
| ECKERT & ZIEGLER | 15,140 | +1,00 % | EQS-Adhoc: Eckert & Ziegler SE: Eckert & Ziegler plant Dividende in Höhe von 0,22 € je Aktie für 2025 | EQS-Ad-hoc: Eckert & Ziegler SE / Schlagwort(e): Dividenden
Eckert & Ziegler plant Dividende in Höhe von 0,22 € je Aktie für 2025
06.03.2026 / 10:36 CET/CEST
Veröffentlichung einer... ► Artikel lesen | |
| ESSILORLUXOTTICA | 213,70 | -1,93 % | BARCLAYS stuft EssilorLuxottica auf 'Overweight' | LONDON (dpa-AFX Analyser) - Die britische Investmentbank Barclays hat die Einstufung für EssilorLuxottica mit einem Kursziel von 355 Euro auf "Overweight" belassen. Nutzzahlen zeigten, dass Smartglasses... ► Artikel lesen | |
| MEDTRONIC | 78,56 | -1,98 % | Medtronic's MiniMed Group Prices IPO Of 28 Mln Shares At $20.00/shr | WASHINGTON (dpa-AFX) - MiniMed Group Inc., a subsidiary of Medtronic plc (MDT), announced the pricing of its initial public offering of 28 million shares of its common stock at a price to the... ► Artikel lesen | |
| ALIGNMENT HEALTHCARE | 18,630 | +0,22 % | Sekundärplatzierung belastet Alignment Healthcare-Aktie | ||
| BRIGHTSPRING HEALTH SERVICES | 40,910 | -2,11 % | BrightSpring Health Services, Inc. Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Full Year 2026 Guidance | LOUISVILLE, Ky., Feb. 27, 2026 (GLOBE NEWSWIRE) -- BrightSpring Health Services, Inc. ("BrightSpring" or the "Company") (NASDAQ: BTSG), a leading provider of home and community-based health services... ► Artikel lesen | |
| STRATEC | 19,500 | +1,14 % | EQS-PVR: STRATEC SE: Release according to Article 40, Section 1 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution | EQS Voting Rights Announcement: STRATEC SE
STRATEC SE: Release according to Article 40, Section 1 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide... ► Artikel lesen | |
| FIREFLY NEUROSCIENCE | 1,890 | +33,57 % | Firefly Neuroscience Skyrockets - Brain Scan Breakthrough Fuels Rally |